EP3843751
COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES
:
EP einkaleyfi: Þýðing ekki lögð inn:
30.7.2020:
27.3.2024:
20847777.8
:
29.7.2040
:
COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES
30.7.2020
27.3.2024
:
Ascentage Pharma (Suzhou) Co., Ltd.:
Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215000, CN
:
Ascentage Pharma Group Corp Limited:
9/F, Wah Yuen Building 149 Queen's Road Central, Hong Kong, HK
:
YANG, Dajun:
Suzhou, Jiangsu 215000, CN
:
ZHAI, Yifan:
Suzhou, Jiangsu 215000, CN
:
FANG, Douglas Dong:
Suzhou, Jiangsu 215000, CN
:
TANG, Qiuqiong:
Suzhou, Jiangsu 215000, CN
:
PCT/CN2019/098625:
31.7.2019:
WO
:
202010631089:
3.7.2020:
CN
:
CN2020105810:
30.7.2020
:
A61K 31/496, A61K 31/55, A61P 35/00, A61P 35/02, A61P 35/04